SM 04755

Drug Profile

SM 04755

Alternative Names: SM04755

Latest Information Update: 02 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Samumed
  • Class Anti-inflammatories; Antineoplastics; Skin disorder therapies; Small molecules
  • Mechanism of Action Wnt signalling pathway inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Colorectal cancer; Gastric cancer; Liver cancer; Pancreatic cancer; Plaque psoriasis; Tendinitis
  • Preclinical Psoriasis; Scleroderma

Most Recent Events

  • 09 Oct 2017 Phase-I clinical trials in Plaque psoriasis in Australia (Topical) (ACTRN12617001178336)
  • 14 Aug 2017 Samumed plans a phase I trial for Plaque psoriasis in Australia (Topical) (ACTRN12617001178336p)
  • 21 Jul 2017 Samumed completes a pharmacokinetic phase I trial in Tendinitis (In volunteers) (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top